Clinical Trial Update: Paracetamol Treatment of the Borderline Significant PDA [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating paracetamol for the treatment of patent ductus arteriosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Paracetamol (acetaminophen)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Patent Ductus Arteriosus | Phase 2 | Status: UNKNOWN